2020
DOI: 10.1073/pnas.2014862117
|View full text |Cite
|
Sign up to set email alerts
|

Draining the FEN1s for cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Its expression is frequently altered by disharmony or mutation in cancer, and these changes contribute to genomic instability and cancer progression [ 11 ]. FEN1 is highly expressed in a variety of tumors, including prostate cancer, neuroblastoma, pancreatic and breast cancer, lung cancer, testicular cancer, glioblastoma, and astrocytoma and so on [ 51 , 52 , 53 , 54 , 55 ]. The expression of FEN1 in different tumors and healthy tissues obtained from the TGCA database is shown in Figure 4 .…”
Section: The Role Of Fen1 In Diseasesmentioning
confidence: 99%
“…Its expression is frequently altered by disharmony or mutation in cancer, and these changes contribute to genomic instability and cancer progression [ 11 ]. FEN1 is highly expressed in a variety of tumors, including prostate cancer, neuroblastoma, pancreatic and breast cancer, lung cancer, testicular cancer, glioblastoma, and astrocytoma and so on [ 51 , 52 , 53 , 54 , 55 ]. The expression of FEN1 in different tumors and healthy tissues obtained from the TGCA database is shown in Figure 4 .…”
Section: The Role Of Fen1 In Diseasesmentioning
confidence: 99%